Refining the Treatment Paradigm Through Targeted Molecular Pathways

Sanjiv S. Agarwala, MD

Video Categories: Pathways

Dr Agarwala outlines the future of cancer treatment as more molecular targets and targeted therapies are identified.
December 3, 2013

Basal Cell Carcinoma Case Studies in Hedgehog Pathway Inhibition

In this final WCMC clinical commentary entitled, The Impact of Hedgehog Pathway Inhibitors on the Management of Patients with Basal Cell Carcinoma, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss how Hedgehog Pathway Inhibitors opened a new chapter of treatment [ Read More ]

October 8, 2016

Exploring the Uses of Fulvestrant

Dr Sibylle Loibl explains how fulvestrant (with or without palbociclib) fits in the treatment paradigm for patients with HR+/ HER2-negative metastatic breast cancer.